Fortis Launches Institute to Revolutionize Gene-Based Disease Treatment

Fortis Healthcare has launched a new medical institute dedicated to genomic medicine, which aims to increase individual and gene-targeted healthcare for complex diseases such as cancer, heart disorders, and neurological conditions. 

The Fortis Institute of Genomic Medicine, unveiled on Tuesday, would use advanced genetic testing to improve diagnosis, initial identity and precision of treatment. According to the hospital, the initiative brings experts from oncology, cardiology, neurology, pathology and genomics together to decode genetic markers and provide tailored care. 

The institute will apply state-of-the-art research to offer customized treatment for patients with aggressive cancer, congenital heart diseases, and rare neurological conditions, focusing on onco- genomics, cardio- genomics and neuro- genomics. 

Top of Form 

“This approach will not only allow for the first detection and risk evaluation, but will also improve the accuracy of treatment in complex medical cases, “said Anil Vinayak, Chief Operating Officer of Fortis Healthcare.” By integrating the genomics in our main offerings, we are re-designing the future of healthcare with data-driven, personal care.”  

Speaking at the launch event held at Fortis Memorial Research Institute (FMRI), Gurugram, Director of Facility Yash Rawat emphasized the importance of genomics in managing India’s increasing burden of non-communicable diseases.  

“Whether it is a child with unexplained anemia or a woman with a family history of breast cancer, genomics enables more accurate treatment strategies, better results and risk decrease,” Rawat said. 

Fortis stated that through genomics, doctors will be better equipped to understand genetic conditions, provide more accurate treatment, and ensure early diagnosis – especially for patients with inheritance or rare disorders.